GPC3 and postural orthostatic tachycardia syndrome: Improvements in the average orthostatic intolerance score were significant at week four (p = 0.012) but did not reach significance at week one (p = 0.089), suggesting a delayed but meaningful therapeutic effect of the SGB treatment.